|
Market Closed -
Nasdaq
21:00:00 19/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 8.070 USD | +3.59% |
|
-5.61% | +3.46% |
| 10-19 | Wedbush Cuts Price Target on BioCryst Pharmaceuticals to $18 From $20, Keeps Outperform Rating | MT |
| 10-05 | Biocryst Pharmaceuticals, Inc. Announces Formation of Scientific Advisory Board | CI |
Stock exchange
Nasdaq
BCRX 8.070 $
+3.59%
78.88M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| BCRX | 8.070USD | +3.59% | 78.88M $ | ||
CBOE
| BCRX | 8.060USD | +3.53% | 2.15M $ | |
|
Mexican S.E.
| BCRX * | 149.50MXN | -1.64% | 155K $ | |
|
Tradegate
| BO1 | 7.194EUR | +3.84% | 3.6K € | |
|
Boerse Muenchen
| BO1 | 7.158EUR | +3.44% | 715.8 € | |
|
Deutsche Boerse AG
| BO1 | 7.076EUR | -0.65% | 0 € | |
|
Börse Stuttgart
| BO1 | 7.166EUR | +3.67% | 0 € | |
|
Berne S.E.
| BO1 | 6.584CHF | -1.70% | 0 CHF |
Quotes 5-day view: BioCryst Pharmaceuticals, Inc.
Delayed Quote Nasdaq
| 13/10/2026 | 14/10/2026 | 15/10/2026 | 16/10/2026 | 19/10/2026 | |
|---|---|---|---|---|---|
| Last | US$8.070 | US$8.050 | US$8.020 | US$7.790 | US$8.070 |
| Volume | 3,043,100 | 5,649,889 | 4,504,339 | 4,431,257 | 9,774,006 |
| Change | -3.47% | -0.25% | -0.37% | -2.87% | +3.59% |
| Opening | US$8.220 | US$8.020 | US$8.105 | US$7.960 | US$7.770 |
| High | US$8.315 | US$8.180 | US$8.240 | US$8.015 | US$8.090 |
| Low | US$8.060 | US$7.970 | US$7.945 | US$7.740 | US$7.770 |
Performance
| 1 day | +3.59% | ||
| 1 week | -5.61% | ||
| Current month | -3.12% | ||
| 1 month | -7.03% | ||
| 3 months | -13.13% | ||
| 6 months | -15.05% | ||
| Current year | +3.46% | ||
| 1 year | +21.72% | ||
| 3 years | +37.71% | ||
| 5 years | -45.91% | ||
| 10 years | +93.99% |
Volumes
marketsDaily volume
9,774,306
Estimated daily volume
9,774,306
Avg. Volume 20 sessions
5,185,489
Daily volume ratio
1.88
Avg. Volume 20 sessions USD
41,846,896.23
Record volume 1
40,095,470
Record volume 2
37,550,050
Record volume 3
37,366,410
Capital turnover ratio
0.02
Float rotation
0.02
Basic data
Market Cap (USD)
1,990,618,467
Net sales (USD)
874,837,000
Number of employees
435
Sales / Employee (USD)
2,011,120
Free-Float
94.69%
Free-Float capitalization (USD)
1,884,886,106
Average Daily Capital Traded
2.1%
Indicators
Moving average 5 days
8.058
Moving average 20 days
8.352
Moving average 50 days
9.033
Moving average 100 days
9.156
Price spread / (MMA5)
-0.15%
Price spread / (MMA20)
+3.50%
Price spread / (MMA50)
+11.93%
Price spread / (MMA100)
+13.46%
STIM
RSI 9 days
38.02
RSI 14 days
39.13
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.59% | -5.61% | +21.72% | +37.71% | 1.99B | |
| +1.52% | -7.16% | +51.66% | +67.41% | 65B | |
| +1.52% | +7.17% | +10.77% | +77.89% | 51.2B | |
| +0.30% | +0.19% | +2.53% | +56.14% | 51.19B | |
| -0.38% | +2.31% | +29.98% | +40.71% | 43.93B | |
| +0.30% | +4.43% | +16.99% | +120.94% | 41.96B | |
| +2.35% | -4.01% | +236.69% | +497.21% | 38.14B | |
| +2.16% | +10.36% | +18.92% | +59.70% | 33.24B | |
| -0.90% | -10.49% | +37.09% | +1.80% | 25.2B | |
| +1.60% | +3.97% | +21.34% | +22.33% | 22.5B | |
| Average | +1.21% | -0.76% | +44.77% | +98.19% | 37.44B | |
| Weighted average by Cap. | +0.99% | -0.01% | +45.90% | +105.99% |
Historical Quotes: BioCryst Pharmaceuticals, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
c409063329c18.bD8VwBp7KuKqo9mxJprug9BoTNbRtueRFDr_PuKQCUI.QQ9Sg0gcGdrPzZKcVtmX9eQOOLeg0IDcZ3aYTa34QBIGVl2TKB4Zltv5tg
| Date | Price | Volume | Total |
|---|---|---|---|
| 21:00:00 | 8.070 | 761,741 | 8,689,377 |
| 20:59:59 | 8.065 | 100 | 7,927,636 |
| 20:59:59 | 8.070 | 100 | 7,927,536 |
| 20:59:59 | 8.070 | 100 | 7,927,436 |
| 20:59:59 | 8.070 | 100 | 7,927,336 |
| 20:59:59 | 8.070 | 100 | 7,927,236 |
| 20:59:59 | 8.070 | 100 | 7,927,136 |
| 20:59:59 | 8.070 | 100 | 7,927,036 |
| 20:59:59 | 8.070 | 100 | 7,926,936 |
| 20:59:59 | 8.070 | 100 | 7,926,836 |
Price Extremes
| 1 week | 7.74 |  | 8.32 |
| 1 month | 7.74 | | 9.04 |
| Current year | 6.23 | | 11.22 |
| 1 year | 6.23 | | 11.22 |
| 3 years | 4.03 | | 11.31 |
| 5 years | 4.03 | | 19.99 |
| 10 years | 1.38 | | 19.99 |
Monthly variations
Annual variations
| 2026 | +3.46% | ||
| 2025 | +3.72% | ||
| 2024 | +25.54% | ||
| 2023 | -47.82% | ||
| 2022 | -17.11% | ||
| 2021 | +85.91% | ||
| 2020 | +115.94% | ||
| 2019 | -57.25% | ||
| 2018 | +64.36% | ||
| 2017 | -22.43% | ||
| 2016 | -38.66% | ||
| 2015 | -15.13% | ||
| 2014 | +60.00% | ||
| 2013 | +435.21% | ||
| 2012 | -42.51% | ||
| 2011 | -52.22% | ||
| 2010 | -19.97% | ||
| 2009 | +371.53% | ||
| 2008 | -77.83% | ||
| 2007 | -46.54% | ||
| 2006 | -30.99% | ||
| 2005 | +189.79% | ||
| 2004 | -15.62% | ||
| 2003 | +613.54% | ||
| 2002 | -75.76% | ||
| 2001 | -40.23% | ||
| 2000 | -77.54% | ||
| 1999 | +321.43% | ||
| 1998 | 0.00% | ||
| 1997 | -57.25% | ||
| 1996 | +77.03% | ||
| 1995 | +100.00% | ||
| 1994 | -28.85% |
- Stock Market
- Stocks
- BCRX Stock
- Quotes BioCryst Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
